Patent details
EP2898887 Title: Combined telomerase inhibitor and gemcitabine for the treatment of cancer
Basic Information
- Publication number:
- EP2898887
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP141988295
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Combined telomerase inhibitor and gemcitabine for the treatment of cancer
- French Title of Invention:
- Inhibiteur de télomérase combiné et gemcitabine pour le traitement du cancer
- German Title of Invention:
- Kombination aus Telomerasehemmer und Gemcitabin zur Behandlung von Krebs
- SPC Number:
Dates
- Filing date:
- 30/10/2007
- Grant date:
- 26/09/2018
- EP Publication Date:
- 29/07/2015
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 26/09/2018
- EP B1 Publication Date:
- 26/09/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 30/10/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 19/09/2018
- Name:
- GERON CORPORATION
- Address:
- 149 Commonwealth Drive, Menlo Park, CA 94025, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 03/10/2018
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- Tressler, Robert J.
- Address:
- United States (US)
2
- Name:
- Go, Ning
- Address:
- United States (US)
Priority
- Priority Number:
- 855583 P
- Priority Date:
- 30/10/2006
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/70;
Publication
European Patent Bulletin
1
- Issue number:
- 201839
- Publication date:
- 26/09/2018
- Description:
- Grant (B1)
2
- Issue number:
- 201844
- Publication date:
- 31/10/2018
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 31/10/2025
- Annual Fee Number:
- 19
- Annual Fee Amount:
- 281 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 11/10/2024
- Last Annual Fee Paid Number:
- 18
- Last Annual Fee Paid Amount:
- 262 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 03/10/2018 | Power Of Attorney | 1 |
| 12/10/2018 | Outgoing Correspondence | 1 |